Where a statement could otherwise be read as a verified fact, attribution language such as "according to FeelGood," "brand-stated," or "brand-reported" identifies it as a brand claim not independently verified by this publication
125,130 In 2022, tirzepatide was approved by the FDA for the treatment of T2DM in the United States
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): A multicentre, randomised, open-label, parallel-group, phase 3 trial
Sin embargo, su uso para este propsito no est aprobado, y se necesita ms investigacin para evaluar su eficacia y seguridad en estas enfermedades dermatolgicas
However, it provides an option for individuals trying to improve their metabolic health without needing big treatments
Sarma, V